These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20370803)

  • 1. Association between polymorphisms in GRIK2 gene and obsessive-compulsive disorder: a family-based study.
    Sampaio AS; Fagerness J; Crane J; Leboyer M; Delorme R; Pauls DL; Stewart SE
    CNS Neurosci Ther; 2011 Jun; 17(3):141-7. PubMed ID: 20370803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.
    Arnold PD; Sicard T; Burroughs E; Richter MA; Kennedy JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):769-76. PubMed ID: 16818866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder.
    Delorme R; Krebs MO; Chabane N; Roy I; Millet B; Mouren-Simeoni MC; Maier W; Bourgeron T; Leboyer M
    Neuroreport; 2004 Mar; 15(4):699-702. PubMed ID: 15094479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.
    Stewart SE; Fagerness JA; Platko J; Smoller JW; Scharf JM; Illmann C; Jenike E; Chabane N; Leboyer M; Delorme R; Jenike MA; Pauls DL
    Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):1027-33. PubMed ID: 17894418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder.
    Stewart SE; Platko J; Fagerness J; Birns J; Jenike E; Smoller JW; Perlis R; Leboyer M; Delorme R; Chabane N; Rauch SL; Jenike MA; Pauls DL
    Arch Gen Psychiatry; 2007 Feb; 64(2):209-14. PubMed ID: 17283288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder.
    Wendland JR; Moya PR; Timpano KR; Anavitarte AP; Kruse MR; Wheaton MG; Ren-Patterson RF; Murphy DL
    Arch Gen Psychiatry; 2009 Apr; 66(4):408-16. PubMed ID: 19349310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms.
    Cai J; Zhang W; Yi Z; Lu W; Wu Z; Chen J; Yu S; Fang Y; Zhang C
    Psychopharmacology (Berl); 2013 Nov; 230(1):49-55. PubMed ID: 23660601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.
    Dickel DE; Veenstra-VanderWeele J; Cox NJ; Wu X; Fischer DJ; Van Etten-Lee M; Himle JA; Leventhal BL; Cook EH; Hanna GL
    Arch Gen Psychiatry; 2006 Jul; 63(7):778-85. PubMed ID: 16818867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMT and MAO-A polymorphisms and obsessive-compulsive disorder: a family-based association study.
    Sampaio AS; Hounie AG; Petribú K; Cappi C; Morais I; Vallada H; do Rosário MC; Stewart SE; Fargeness J; Mathews C; Arnold P; Hanna GL; Richter M; Kennedy J; Fontenelle L; de Bragança Pereira CA; Pauls DL; Miguel EC
    PLoS One; 2015; 10(3):e0119592. PubMed ID: 25793616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
    Alonso P; Gratacòs M; Menchón JM; Saiz-Ruiz J; Segalàs C; Baca-García E; Labad J; Fernández-Piqueras J; Real E; Vaquero C; Pérez M; Dolengevich H; González JR; Bayés M; de Cid R; Vallejo J; Estivill X
    Biol Psychiatry; 2008 Mar; 63(6):619-28. PubMed ID: 17884018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder.
    Alonso P; Gratacós M; Segalàs C; Escaramís G; Real E; Bayés M; Labad J; López-Solà C; Estivill X; Menchón JM
    J Psychiatry Neurosci; 2012 Jul; 37(4):273-81. PubMed ID: 22433450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study.
    Voyiaziakis E; Evgrafov O; Li D; Yoon HJ; Tabares P; Samuels J; Wang Y; Riddle MA; Grados MA; Bienvenu OJ; Shugart YY; Liang KY; Greenberg BD; Rasmussen SA; Murphy DL; Wendland JR; McCracken JT; Piacentini J; Rauch SL; Pauls DL; Nestadt G; Fyer AJ; Knowles JA
    Mol Psychiatry; 2011 Jan; 16(1):108-20. PubMed ID: 19806148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder.
    Dickel DE; Veenstra-VanderWeele J; Bivens NC; Wu X; Fischer DJ; Van Etten-Lee M; Himle JA; Leventhal BL; Cook EH; Hanna GL
    Biol Psychiatry; 2007 Feb; 61(3):322-9. PubMed ID: 17241828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OLIG2 gene polymorphisms are associated with nasty, unpleasant and uncontrollable thoughts in obsessive-compulsive disorder.
    Vieira-Fonseca T; Fontenelle LF; Kohlrausch FB
    J Clin Neurosci; 2019 Dec; 70():202-207. PubMed ID: 31431405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin receptor gene polymorphisms exert a modulating effect on the onset age in patients with obsessive-compulsive disorder.
    Kang JI; Kim HW; Kim CH; Hwang EH; Kim SJ
    Psychoneuroendocrinology; 2017 Dec; 86():45-52. PubMed ID: 28915380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid obsessive-compulsive personality disorder in obsessive-compulsive disorder (OCD): a marker of severity.
    Lochner C; Serebro P; van der Merwe L; Hemmings S; Kinnear C; Seedat S; Stein DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1087-92. PubMed ID: 21411045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS.
    Mattheisen M; Samuels JF; Wang Y; Greenberg BD; Fyer AJ; McCracken JT; Geller DA; Murphy DL; Knowles JA; Grados MA; Riddle MA; Rasmussen SA; McLaughlin NC; Nurmi EL; Askland KD; Qin HD; Cullen BA; Piacentini J; Pauls DL; Bienvenu OJ; Stewart SE; Liang KY; Goes FS; Maher B; Pulver AE; Shugart YY; Valle D; Lange C; Nestadt G
    Mol Psychiatry; 2015 Mar; 20(3):337-44. PubMed ID: 24821223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder.
    Zai G; Arnold P; Burroughs E; Barr CL; Richter MA; Kennedy JL
    Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):25-9. PubMed ID: 15685626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic susceptibility to obsessive-compulsive hoarding: the contribution of neurotrophic tyrosine kinase receptor type 3 gene.
    Alonso P; Gratacòs M; Menchón JM; Segalàs C; González JR; Labad J; Bayés M; Real E; de Cid R; Pertusa A; Escaramís G; Vallejo J; Estivill X
    Genes Brain Behav; 2008 Oct; 7(7):778-85. PubMed ID: 18616610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the brain-derived neurotrophic factor SNP rs2883187 in the phenotypic expression of obsessive-compulsive disorder.
    Tükel R; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Direskeneli GS
    J Clin Neurosci; 2014 May; 21(5):790-3. PubMed ID: 24291483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.